Musely Secures $360M Non-Dilutive Funding from General Catalyst
Musely, a telemedicine platform, has raised $360 million in non-dilutive capital from General Catalyst’s Customer Value Fund, avoiding equity dilution. The company, which is cash flow positive and growing revenue by 50% annually, opted for a revenue-sharing agreement instead of traditional equity or loans. This move highlights a new financing model for DTC companies.
Topics: DTC healthcare funding revenue-sharing startup growth telemedicine